AUA 2021: TOAD: Warts and All? Subgroup Analyses Revealing Differential Treatment Effects in the Timing of Androgen Deprivation Trial

(UroToday.com) In this presented study by Dr. Kristian Stensland takes a deeper dive into the TOAD trial specifically assessing whether prior androgen deprivation therapy (ADT) use impacted the efficacy of ADT timing after PSA relapse in men with PSA-relapsed and non-curable prostate cancer.